SKYE vs UTHR · $25.0M cap vs P/E 20, rev $1.56B
Skye Bioscience, Inc. Common Stock (SKYE) versus United Therapeutics Corporation (UTHR) — a side-by-side from cached financials, not a winner call.
Skye Bioscience, Inc. Common Stock (SKYE) is a biotechnology company listed on NASDAQ.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
SKYE does not have a complete income-statement cache yet.
Latest reported UTHR revenue for 2026-06-30 was $1.56B. Net income was $607.9M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
SKYE currently screens at market cap $25.0M. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Not investment advice. Open the SKYE and UTHR stock pages for the full models.
Not investment advice.